Mark Jacobson - Aug 9, 2024 Form 4 Insider Report for Axsome Therapeutics, Inc. (AXSM)

Role
Chief Operating Officer
Signature
/s/ Mark Jacobson
Stock symbol
AXSM
Transactions as of
Aug 9, 2024
Transactions value $
-$3,829,623
Form type
4
Date filed
8/9/2024, 07:27 PM
Previous filing
May 29, 2024
Next filing
Feb 25, 2025
SEC
View on sec.gov

Transactions Table

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXSM Stock Option (Right to Buy) Options Exercise $0 -47.7K -100% $0.00* 0 Aug 9, 2024 Common Stock 47.7K $4.04 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Represents an exercise of stock options prior to the 10-year expiration date of such options, which would occur later this year.
F2 Such transaction was pursuant to a pre-approved 10b5-1 plan.
F3 Represents the subsequent sale of the underlying shares of the aforementioned exercise of stock options.
F4 Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $82.705 and $85.975.